Japan Review/Outlook: Pricing Tweaks Considered After Year Of Change

 
• By Lisa Takagi

After a year of revising and opening up its regulations for new drugs in 2023, Japan is aiming to add more reimbursement pricing premiums for innovative medicines in 2024, while cautiously discussing other detailed revisions to regulations and the pricing system.

Japan Outlook
Japan has announced an outline plan for 2024's annual NHI price revision • Source: Shutterstock

More from Japan

More from Asia